Intended Indication Major Depressive Disorders With And Without Anxiety clinical trials

Explore recruiting intended indication major depressive disorders with and without anxiety clinical trials.

Also recruiting in Europe

Intended Indication Major Depressive Disorders With And Without Anxiety trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A randomized, two-way, crossover, two parallel groups study to compare the bioavailability of 150 mg and 300 mg trazodone hydrochloride tablets (new polymer) (Angelini Pharma S.p.A.) vs. 150 mg and 300 mg trazodone hydrochloride Contramid® tablets (Angelini Pharma S.p.A.) at steady-state

Germany

Human Pharmacology (Phase I)- Bioequivalence Study EU CTIS Study details

Intended Indication Major Depressive Disorders With And Without Anxiety trials by city

Intended Indication Major Depressive Disorders With And Without Anxiety in Toronto Intended Indication Major Depressive Disorders With And Without Anxiety in Vancouver Intended Indication Major Depressive Disorders With And Without Anxiety in Montreal Intended Indication Major Depressive Disorders With And Without Anxiety in Calgary Intended Indication Major Depressive Disorders With And Without Anxiety in Edmonton Intended Indication Major Depressive Disorders With And Without Anxiety in Ottawa Intended Indication Major Depressive Disorders With And Without Anxiety in Winnipeg Intended Indication Major Depressive Disorders With And Without Anxiety in Quebec City Intended Indication Major Depressive Disorders With And Without Anxiety in Hamilton Intended Indication Major Depressive Disorders With And Without Anxiety in Kitchener Intended Indication Major Depressive Disorders With And Without Anxiety in London Intended Indication Major Depressive Disorders With And Without Anxiety in Halifax Intended Indication Major Depressive Disorders With And Without Anxiety in New York Intended Indication Major Depressive Disorders With And Without Anxiety in Los Angeles Intended Indication Major Depressive Disorders With And Without Anxiety in Chicago Intended Indication Major Depressive Disorders With And Without Anxiety in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease